Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses.

Transcatheter aortic valves (TAVs) are a promising treatment for high risk surgical patients suffering from degeneration of previously implanted bioprostheses (valve-in-valve therapy).